David Neil Hayes
Founder at GeneCentric Therapeutics, Inc.
Profile
David Neil Hayes is the founder of GeneCentric Therapeutics, Inc. which was founded in 2011.
He held the title of Director at the company.
Currently, he is the Director-Clinical Bioinformatics at North Carolina Cancer Hospital.
Dr. Hayes has an undergraduate degree from Davidson College, a graduate degree from Harvard T.H.
Chan School of Public Health, and a doctorate from The University of North Carolina at Charlotte.
David Neil Hayes active positions
| Companies | Position | Start |
|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Founder | 2010-12-31 |
North Carolina Cancer Hospital
 North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Corporate Officer/Principal | - |
Training of David Neil Hayes
| Davidson College | Undergraduate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
North Carolina Cancer Hospital
North Carolina Cancer Hospital Hospital/Nursing ManagementHealth Services The North Carolina Cancer Hospital is a cancer research and treatment center located at the University of North Carolina at Chapel Hill. The American company serves patients at the N.C. Cancer Hospital. | Health Services |
- Stock Market
- Insiders
- David Neil Hayes
